Dual-Responsive Biomimetic Nanoplatform for Cascade Synergistic Therapy of Endometrial Cancer
ACS Applied Bio Materials · 2026
DOI: 10.1021/acsabm.6c00563 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Bio Materials, 2026. Verfasst von Huaibin Yu und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine and Health, Zhengzhou Advanced Research Institute of Harbin Institute of Technology, Zhengzhou450000, P. R. China. Hauptthemen laut MEDLINE: Biomimetic Materials, Endometrial Neoplasms, Doxorubicin, Biocompatible Materials. Die Arbeit nennt 36 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Postdoctoral Research Foundation of China.
Abstract (Originalsprache)
Endometrial cancer is a common malignant tumor in the female reproductive system. Traditional chemotherapy has limitations such as poor targeting, dose-limiting toxicity, and treatment intensity restrictions. To address these issues, this study constructed an intelligent nanoplatform–GOD-Fe3+&DOX-Membrane@Polymer (GOD-Fe3+&DM@Poly.)–based on reversible addition-fragmentation chain transfer (RAFT) polymerization technology. The incorporation of pyridine disulfide bonds as polymer side chains through RAFT polymerization facilitated the precise covalent immobilization of glucose oxidase (GOD), effectively mitigating the leakage issues commonly observed with physical encapsulation methods. Concurrently, benzylboronic acid moieties were integrated into the polymer backbone, enabling the formation of reversible borate ester linkages with sialic acid residues present on the membranes of HEC-1A cancer cells. This interaction promoted homologous targeting and substantially improved their intratumoral enrichment efficiency. In addition, GOD-mediated starvation therapy and Fe3+-triggered chemodynamic therapy construct a cascade reaction: GOD consumes tumor glucose to produce H2O2, which is converted into highly toxic hydroxyl radicals through the Fe3+-mediated Fenton reaction, amplifying tumor oxidative stress to initiate ferroptosis. This integration establishes a valuable technical framework for the development of multifunctional and stimuli-responsive nanomedicines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine and Health, Zhengzhou Advanced Research Institute of Harbin Institute of Technology, Zhengzhou450000, P. R. China.
- School of Medicine and Health, Harbin Institute of Technology , Harbin150040, P. R. China.
- Shenzhen Maternity and Child Healthcare Hospital, Southern Medical University , Shenzhen518028, P. R. China.
- Shenzhen School of Clinical Medicine, Southern Medical University , Shenzhen518028, P. R. China.
- School of Biomedical Engineering, Shenzhen University Medical School, Shenzhen University, Shenzhen518055, P. R. China.
- The First Affiliated Hospital of Zhengzhou University , Zhengzhou450000, P. R. China.
ORCID-Profile: Huaibin Yu
Förderung
- National Natural Science Foundation of China
- Postdoctoral Research Foundation of China
Zitieren
APA
Yu, H., Miao, Z., Wang, M., Guo, T., Zhang, D., Zha, Z., & Jin, P. (2026). Dual-Responsive Biomimetic Nanoplatform for Cascade Synergistic Therapy of Endometrial Cancer. ACS Applied Bio Materials. https://doi.org/10.1021/acsabm.6c00563
Vancouver
Yu H, Miao Z, Wang M, Guo T, Zhang D, Zha Z, et al. Dual-Responsive Biomimetic Nanoplatform for Cascade Synergistic Therapy of Endometrial Cancer. ACS Applied Bio Materials. 2026. doi:10.1021/acsabm.6c00563
BibTeX
@article{Yu2026,
author = {Yu, Huaibin and Miao, Zhuorong and Wang, Meng and Guo, Tianyi and Zhang, Deyuan and Zha, Zhengbao and Jin, Ping},
title = {Dual-Responsive Biomimetic Nanoplatform for Cascade Synergistic Therapy of Endometrial Cancer},
journal = {ACS Applied Bio Materials},
year = {2026},
doi = {10.1021/acsabm.6c00563}
}
EUVIMED